View all data FOR FREE!
Create an account today, no credit card required.
| Issue Type | XXXX |
|---|---|
| Country | United States |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2030-03-03 |
| Par Value | 2000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 650.00 |
| Coupon | 4.9 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 650 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This AstraZeneca Finance LLC corporate note has a 4.90% fixed rate coupon paid on a semi-annual basis. It was issued on March 03, 2023 with an issue size of 650.00 million USD and matures on March 03, 2030 with a last coupon date of September 03, 2029. |
AstraZeneca Finance LLC, founded in 2009 and headquartered in the United Kingdom, serves as the financing arm of pharmaceutical giant AstraZeneca PLC. The company is dedicated to facilitating funding for its parent organization through a variety of financial instruments and services. Key offerings include corporate bonds, loans, and debt issuances, aimed at supporting AstraZeneca’s research and development efforts globally.